Bio News
Researchers at Stanford University developed a “virtual biotech” in which specialized AI agents work together. A virtual chief scientific officer (CSO) coordinates agents in four areas: target discovery, safety assessment, treatment selection and clinical development.
The researchers analyzed about 56,000 clinical trials to propose a treatment strategy for lung cancer and develop hypotheses about why discontinued trials failed.
BIOBOOK TEAM
biobookmedia@biobook.co.krRoche’s New Drug for Uveitic Macular Edema Faces FDA Decision in July 2027
BMS Reports Concurrent Phase 3 Success in Idiopathic Pulmonary Fibrosis and Solid Tumors
Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
